Sonia Hermoso Durán | Biochemistry | Women Researcher Award

Posted on by ScienceFather

Sonia Hermoso Durán | Biochemistry | Women Researcher Award

Dr Sonia Hermoso Durán, Universidad de Zaragoza, Spain

Dr. Sonia Hermoso Durán is a highly accomplished researcher in the field of biochemistry and molecular biology. Her extensive work experience, particularly as a predoctoral fellow at Aragón Health Research Institute, coupled with her advanced education in biochemistry and molecular biology, makes her a strong candidate for the Women Researcher Award.

Publication Profile

Google Scholar

Work Experience

Dr. Hermoso Durán has been a Predoctoral Fellow at the Aragón Health Research Institute (IIS Aragón) from January 2020 to June 2024, funded by a prestigious P-FIS grant from the Carlos III Health Institute. She also served as a Senior Research Technician on critical clinical research projects focused on digestive tumors and colon cancer.

Educational Background

Dr. Hermoso Durán is completing her PhD in Biochemistry and Molecular Biology at the University of Zaragoza. She holds a Specialist degree in Laboratory Medicine, with further education in applied statistics and machine learning for clinical laboratory applications.

Research Stays

Dr. Hermoso Durán has completed research stays in top international research institutions, including the Kolling Institute in Sydney, Australia, and the Cancer Research Center of Marseille, where she gained significant experience in cancer research.

Publications

Dr. Hermoso Durán has published several notable studies, including research on the development of machine learning models for diagnosing pancreatic cancer from serum samples, published in Advanced Intelligent Systems. Other studies include contributions to colorectal cancer diagnostics and investigations on the potential use of thermal liquid biopsy for multiple sclerosis detection.

Grants and Conferences

She has obtained multiple research grants, including those from the Carlos III Health Institute and Aragón Health Research Institute, supporting her stays in renowned research centers. Additionally, Dr. Hermoso Durán has delivered oral talks at prestigious conferences such as the European Pancreatic Club and Spanish Gastroenterology Association.

Publication Top Notes

Estudio de la ferropenia en el laboratorio clínico

False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use

Thermal liquid biopsy (TLB) focused on benign and premalignant pancreatic cyst diagnosis

Vertical cutoff methods in serum protein electrophoresis for the measurement of monoclonal protein concentrations: Which is best?

Thermal liquid biopsy (TLB) of blood plasma as a potential tool to help in the early diagnosis of multiple sclerosis

Fluorescence liquid biopsy for cancer detection is improved by using cationic dendronized hyperbranched polymer

Bowel preparation for colonoscopy changes serum composition as detected by thermal liquid biopsy and fluorescence spectroscopy

Conclusion

Dr. Sonia Hermoso Durán’s extensive research background, numerous grants, high-impact publications, and recognition through conference presentations clearly demonstrate her qualifications. Her contributions to biochemistry and molecular biology, particularly in cancer diagnostics, make her an outstanding candidate for the Women Researcher Award.

Asif shahzad | Medical Biochemistry | Best Researcher Award

Posted on by ScienceFather

Dr. Asif shahzad | Medical Biochemistry | Best Researcher Award

Dr. Asif shahzad, Kunming Medical University Yunnan China

Dr. Asif Shahzad is a Research Associate in Medical Biochemistry at Kunming Medical University, China, specializing in metabolic reprogramming of clear cell renal cell carcinoma (ccRCC). With 15+ international publications, his research also focuses on natural compounds in oncology and synbiotic feed supplements for poultry growth. He previously worked on HCV treatment and poultry nutrition at Government College University, Faisalabad, Pakistan. Dr. Shahzad actively collaborates with global researchers and is a member of several scientific organizations, contributing significantly to advancements in biochemistry and oncology. 🌱🧪🔬

Publication profile

Google Scholar

Academic and Professional Background

Dr. Asif Shahzad is a Research Associate in Medical Biochemistry and Molecular Biology at Kunming Medical University, Yunnan, China, under the mentorship of Prof. Dr. Zhang Qiao. His work focuses on metabolic reprogramming in clear cell renal cell carcinoma (ccRCC), with 15+ publications in high-impact journals. Previously, he contributed to research at Government College University, Faisalabad, Pakistan, exploring serine protease inhibitors for HCV treatment and developing synbiotic feed supplements for poultry under the guidance of Prof. Dr. Shagufta Kamal. He is an active member of various biochemistry and oncology societies, demonstrating a strong commitment to advancing scientific knowledge.

Research and Innovations

Dr. Shahzad has participated in numerous research projects. He was a Research Associate on an HEC-funded project that explored serine protease inhibitors as a novel therapeutic approach for HCV. He also contributed to a PHEC project developing a synbiotic feed supplement for poultry. Currently, he leads a project on bioactive peptides from plant species and their potential therapeutic effects against HCV. His ongoing research includes a study on Moringa oleifera’s anti-ccRCC properties. His work exemplifies a versatile research portfolio that bridges human health and animal nutrition innovations.

Areas of Research

Dr. Shahzad’s research interests span several fields, including metabolic reprogramming in cancer, natural compounds in oncology, synbiotics in animal nutrition, amino acid analysis, and biocatalysis. His multidisciplinary research combines both human and animal health sciences, showcasing his ability to contribute to diverse scientific fields.

Publication Top Notes

  • An overview of free Radicals & antioxidants and its Deleterious actions 🧪📚 A Shahzad, S Hussain, N Anwar, A Karim, U Aeman, MJ Iqbal | Cited by 4 | 2021
  • Modulation of Metabolic Pathways and Protection against Cadmium-Induced Disruptions with Taxifolin-Enriched Extract 🧬🛡️ MF Khalid, MSH Akash, K Rehman, A Shahzad, A Nadeem | Cited by 1 | 2024
  • Biochemical investigation of association of arsenic exposed polymorphic variants and disease susceptibility 🔬🧬 SM Shoaib, S Afzal, MSH Akash, K Rehman, A Hussain, A Nadeem, A Shahzad | 2025
  • Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics 💊🧫 A Shahzad, Z Teng, M Yameen, W Liu, K Cui, X Liu, Y Sun, Q Duan | 2024
  • Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus 🦠💊 S Kamal, A Shahzad, K Rehman, K Tariq, MSH Akash, M Imran, MA Assiri | 2024
  • Biochemical Investigation of Therapeutic Efficacy of Berberine-Enriched Extract in Streptozotocin-Induced Metabolic Impairment 🧪🩺 MSH Akash, S Yaqoob, K Rehman, A Hussain, Z Chauhdary, A Nadeem, A Shahzad | 2024
  • Biosynthesis and Multifaceted Characterization of Breynia nivosa-Derived Silver Nanoparticles: An Eco-Friendly Approach for Biomedical Applications 🌿⚗️ K Irshad, MSH Akash, K Rehman, A Nadeem, A Shahzad | 2024
  • The Impact of Gut Bacterial Metabolites on Brain Disorder 🧠🦠 A Shahzad, S Hussain, R Mehmood, MN Jaan | 2022
  • A Medical Approach for Rhinoplasty 👃🩺 A Shahzad, S Hussain, A Karim, HMA Farooq, S Azam, U Hameed | 2022
  • Impact of Obesity in Male and Female Infertility ⚖️🧬 DEM Razia, A Shahzad, S Hussain, NB Qureshi, N Anwaar, A Aftab | 2021


Conclusion

Dr. Asif Shahzad’s innovative research in cancer metabolism and animal nutrition, combined with his editorial, collaborative, and professional contributions, makes him a strong candidate for the Best Researcher Award. His research’s impact on both human and animal health sectors aligns with the award’s recognition of excellence and innovation in scientific inquiry.